Financial statements Millennium Pharma
Balance sheet data of MILLENNIUM PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 256 852,75 | 1 354 900,21 | 1 049 582,56 | 1 237 553,70 | 1 596 346,89 | 1 846 825,25 |
| A. Fixed assets | 25 486,97 | 167 593,98 | 114 887,63 | 234 158,19 | 271 109,00 | 282 242,55 |
| B. Current assets | 231 365,78 | 1 187 306,23 | 934 694,93 | 1 003 395,51 | 1 325 237,89 | 1 564 582,70 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 256 852,75 | 1 354 900,21 | 1 049 582,56 | 1 237 553,70 | 1 596 346,89 | 1 846 825,25 |
| A. Equity | -284 817,64 | -567 180,67 | -856 015,83 | -1 193 118,43 | -1 554 117,97 | -2 034 598,45 |
| B. Liabilities and provisions for liabilities | 541 670,39 | 1 922 080,88 | 1 905 598,39 | 2 430 672,13 | 3 150 464,86 | 3 881 423,70 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 503 445,46 | 1 883 426,23 | 1 838 624,64 | 2 376 047,63 | 3 045 118,73 | 3 808 541,36 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.